A retrospective study of mTOR inhibitor treatment in patients with TSC under the age of 2 years (n = 17) found everolimus to be efficacious and safe for infants with cardiac rhabdomyoma, SEGA and epilepsy.106. Here, MTOR is linked to tuberous sclerosis.